Regulatory readiness is often the critical path item for veterinary pharmaceutical market entry. Incomplete documentation and unclear sequencing create avoidable delay.
A practical approach begins with requirement mapping, gap analysis, and a realistic timeline aligned to commercial launch assumptions.
Companies that treat regulatory affairs as a strategic workstream—not an administrative afterthought—protect both time-to-market and partner confidence.